Cerecor Inc. Business Finance Contracts & Agreements
69 Contracts & Agreements
- Contribution Agreements (1 contract)
- Credit Agreements (2)
- Exchange Agreements (1)
- Forbearance Agreements (2)
- Guarantee Agreements (1)
- Investor Rights Agreements (1)
- Loan Agreements (10)
- Note Agreements (2)
- Purchase Agreements (14)
- Registration Rights Agreements (7)
- Stock Agreements (6)
- Underwriting Agreements (7)
- Waiver Agreements (1)
- Warrant Agreements (14)
- Asset Purchase Agreement, dated December 6, 2023, by and among AlmataBio, Inc., Leap Therapeutics, Inc., and Flame Biosciences LLC (Filed With SEC on May 13, 2024)
- Registration Rights Agreement (Filed With SEC on March 28, 2024)
- Securities Purchase Agreement, dated March (Filed With SEC on March 28, 2024)
- Form of Warrant (Filed With SEC on March 28, 2024)
- Payoff Letter, dated as of September 22, 2023, between Avalo Therapeutics, Inc. and Horizon Credit II LLC, Horizon Funding Trust 2019-1, Horizon Funding I, LLC, Powerscourt... (Filed With SEC on September 26, 2023)
- First Amendment to Loan Agreement, dated as of September 13, 2023, between Avalo Therapeutics, Inc. and Horizon Credit II LLC, Horizon Funding Trust 2019-1, Horizon Funding I,... (Filed With SEC on September 13, 2023)
- Third Forbearance Agreement, dated as of September (Filed With SEC on September 13, 2023)
- Purchase Agreement, dated September 11, 2023, by and between AUG Therapeutics, LLC and Avalo Therapeutics, Inc (Filed With SEC on September 12, 2023)
- Second Forbearance Agreement, dated as of August 14, 2023, between Avalo Therapeutics, Inc. and Horizon Credit II LLC, Horizon Funding Trust 2019-1, Horizon Funding I, LLC,... (Filed With SEC on August 14, 2023)
- Forbearance Agreement, dated as of July (Filed With SEC on July 21, 2023)
- Exchange Agreement, dated as of (Filed With SEC on June 2, 2023)
- Form of Exchange Warrant (Filed With SEC on June 2, 2023)
- Form of Warrant (Filed With SEC on February 3, 2023)
- Underwriting Agreement, dated February 2, 2023, between Avalo Therapeutics, Inc., SVB Securities LLC and RBC Capital Markets, LLC, as representatives of the several underwriters... (Filed With SEC on February 3, 2023)
- Purchase Agreement, dated November 4, 2022, by and between ES Therapeutics, LLC and Avalo Therapeutics, Inc (Filed With SEC on November 7, 2022)
- Waiver, dated August (Filed With SEC on August 11, 2022)
- Underwriting Agreement, dated September (Filed With SEC on September 15, 2021)
- Loan Agreement, dated June 4, 2021, by and between Horizon Technology Finance Corporation, Powerscourt Investments XXV, LP and Cerecor Inc (Filed With SEC on August 2, 2021)
- Warrant to Purchase Common Stock (Loan H) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan G) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan F) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan E) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan D) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan C) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan B) issued (Filed With SEC on June 8, 2021)
- Warrant to Purchase Common Stock (Loan A) issued (Filed With SEC on June 8, 2021)
- Stock Option Agreement, dated (Filed With SEC on March 1, 2021)
- Form of Pre-Funded Warrant (Filed With SEC on January 8, 2021)
- Underwriting Agreement, dated January 7, 2021, by and between Cerecor Inc. and Jefferies LLC (Filed With SEC on January 8, 2021)
- Underwriting Agreement, dated June 9, 2020, by and between Cerecor Inc. and Oppenheimer & Co. Inc (Filed With SEC on June 9, 2020)
- Registration Rights Agreement, dated March 17, 2020, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on March 18, 2020)
- Securities Purchase Agreement, dated March 17, 2020, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on March 18, 2020)
- Form of Securities Purchase Agreement, dated February 3, 2020 (Filed With SEC on February 4, 2020)
- Contingent Value Rights Agreement, effective February 3, 2020, by and between Cerecor Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on February 3, 2020)
- Promissory Note for Operating Expenses, dated December 5, 2019, by and between Cerecor Inc. and Aevi Genomic Medicine, Inc (Filed With SEC on December 5, 2019)
- Promissory Note for License Expenses, dated December 5, 2019, by and between Cerecor Inc. and Aevi Genomic Medicine, Inc (Filed With SEC on December 5, 2019)
- Contribution Agreement, dated November 1, 2019, by and between Cerecor Inc., Armistice Capital Master Fund, Ltd. And Avadel US Holdings Inc (Filed With SEC on November 4, 2019)
- Guarantee dated November 1, 2019, by and between Cerecor Inc. and Deerfield CSF, LLC, Peter Steelman and James Flynn (Filed With SEC on November 4, 2019)
- First Amendment to the Asset Purchase Agreement, dated November 1, 2019, by and between Cerecor Inc. and Aytu Bioscience, Inc (Filed With SEC on November 4, 2019)
- Registration Rights Agreement, dated September 4, 2019, between Cerecor Inc. and the investor(s) named therein (Filed With SEC on September 9, 2019)
